Scribd Logo
Upload

Welcome to Scribd!

  • R1MC Pedia RHD Drug Study Ni Holy

    Uploaded by

    Holyver Tabarnilla
    7 views2 pages
    This document provides information about a drug study conducted by nursing student Holyver Tabarnilla during their clinical rotation in the pediatric ward. It details the drug cilostazol, including its classification as a platelet aggregation inhibitor, mechanism of action in inhibiting phosphodiesterase and suppressing camp increase in platelets, indications for intermittent claudication pain in the legs that occurs with walking, contraindications of bleeding disorders and active pathological bleeding, potential adverse effects of heart problems, and the nurse's responsibilities in implementing therapeutic and ambulation activities to augment the drug's effect and promote increased walking distance.

    Original Description:

    Original Title

    R1MC PEDIA RHD DRUG STUDY NI HOLY

    Copyright

    © © All Rights Reserved

    Available Formats

    DOCX, PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Report this Document
    This document provides information about a drug study conducted by nursing student Holyver Tabarnilla during their clinical rotation in the pediatric ward. It details the drug cilostazol, including its classification as a platelet aggregation inhibitor, mechanism of action in inhibiting phosphodiesterase and suppressing camp increase in platelets, indications for intermittent claudication pain in the legs that occurs with walking, contraindications of bleeding disorders and active pathological bleeding, potential adverse effects of heart problems, and the nurse's responsibilities in implementing therapeutic and ambulation activities to augment the drug's effect and promote increased walking distance.

    Copyright:

    © All Rights Reserved
    Download as DOCX, PDF, TXT or read online from Scribd
    Flag for inappropriate content
    Download as docx, pdf, or txt
    7 views2 pages

    R1MC Pedia RHD Drug Study Ni Holy

    Uploaded by

    Holyver Tabarnilla
    This document provides information about a drug study conducted by nursing student Holyver Tabarnilla during their clinical rotation in the pediatric ward. It details the drug cilostazol, including its classification as a platelet aggregation inhibitor, mechanism of action in inhibiting phosphodiesterase and suppressing camp increase in platelets, indications for intermittent claudication pain in the legs that occurs with walking, contraindications of bleeding disorders and active pathological bleeding, potential adverse effects of heart problems, and the nurse's responsibilities in implementing therapeutic and ambulation activities to augment the drug's effect and promote increased walking distance.

    Copyright:

    © All Rights Reserved
    Download as DOCX, PDF, TXT or read online from Scribd
    Flag for inappropriate content
    Download as docx, pdf, or txt
    of 2

    NORTHERN LUZON ADVENTIST COLLEGE

    Artacho, Sison, Pangasinan


    A SEVENTH-DAY ADVENTIST INSTITUTION
    Accredited by ACSCU -AAI & IBE-AA
    SCHOOL OF NURSING
    Tel. No. 075 -632 -2290 http://www.nlac.edu.p h e-mail address: Info@nlac.edu.ph ; dean.nursing.nlac@gmail.com

    DRUG STUDY
    Name of Student: Holyver Tabarnilla Subject/Area of Exposure: R1MC/PEDIA WARD

    Name of CI: Ervin Gelido,Rn


    Name of Drug Classification Mechanism of Indication Contraindication Adverse Effect Nursing
    Action Responsibilities
    Generic Name PLATELET- INHIBITING FOR THE HYPERSENSITI MAY IMPLEMENT
    AGGREGATI PHOSPHODIESTER ALLEVATION VITY THERAPEUTIC
    CILOSTASOL CAUSE
    ON ASE ACTIVITY OF HEMOSTATIC
    AND
    INHIBITOR AND SYMPTOMS DISORDERS HEART
    OR ACTIVE AMBULATION
    SUPPRESSING OF PROBLEM ACTIVITIES
    Brand Name: PATHOLOG
    Camp INCREASE IN INTERMITTE S
    PLETAL IC TO AUGMENT
    PLATELETS NT BLEEDING
    AND BLOOD CLAUDICATI THE EFFECT
    Dosage: VESSELS ON OF DRUGS
    1 TAB 50MG LEADING TO -PAIN IN THE THERAPY
    INHIBITION LEGS THAT AND
    OF PLATELETS OCCURS WITH PROMOTE
    Route: AGGREGATION WALKING AND INCREASED
    AND DISSAPPERS WALKING
    VASODILATION WITH REST DISTANCE
    ORAL

    Frequency:
    BID

    You might also like